Difference between revisions of "Roux-en-Y gastric bypass"
Jump to navigation Jump to search
|Line 26:||Line 26:|
Latest revision as of 11:12, 28 November 2019
Roux-en-Y gastric bypass is procedure used to treat obesity.
- Treatment for obesity.
- Mortality ~0.15%.
- A segment of small bowel is excised as part of the procedure.
- Normal small bowel wall.
Small Bowel, Excision During Gastric Bypass: - Small bowel wall within normal limits.
Small Bowel, Excision during Roux-en-Y Gastric Bypass: - Small bowel wall within normal limits.
Small Bowel, Excision during Gastric Bypass: - Small bowel wall with increased intraepithelial lymphocytes, otherwise within normal limits, see comment. Comment: The increased intraepithelial lymphocytes are likely explained by obesity; however, other causes (such as infection, inflammatory bowel disease and celiac disease) should be considered within the clinical context.
- Benotti, P.; Wood, GC.; Winegar, DA.; Petrick, AT.; Still, CD.; Argyropoulos, G.; Gerhard, GS. (Jan 2014). "Risk factors associated with mortality after Roux-en-Y gastric bypass surgery.". Ann Surg 259 (1): 123-30. doi:10.1097/SLA.0b013e31828a0ee4. PMID 23470583.
- Harpaz, N.; Levi, GS.; Yurovitsky, A.; Kini, S. (Mar 2007). "Intraepithelial lymphocytosis in architecturally normal small intestinal mucosa: association with morbid obesity.". Arch Pathol Lab Med 131 (3): 344; author reply 344. doi:10.1043/1543-2165(2007)131[344b:IR]2.0.CO;2. PMID 17516730.